Equifax (EFX) Stock Forecast & Price Target

Q: What analysts cover Equifax?

Equifax has been rated by research analysts at Barclays , BMO Capital Markets , BNP Paribas Exane , Citigroup , Deutsche Bank Aktiengesellschaft , JPMorgan Chase & Co. , Mizuho , Morgan Stanley , Needham & Company LLC , Robert W. Baird , Rothschild & Co Redburn , Royal Bank Of Canada , The Goldman Sachs Group , UBS Group , Weiss Ratings , and Wells Fargo & Company in the past 90 days.

$171.96 -5.10 (-2.88%)

As of 12:42 PM Eastern

Compare

Equifax - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 21 Analyst Ratings

Sell
0

Hold
6

Buy
15

Based on 21 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 21 analysts, 6 have given a hold rating, and 15 have given a buy rating for EFX.

Consensus Price Target

$215.16
25.12% Upside

According to the 21 analysts' twelve-month price targets for Equifax, the average price target is $215.16. The highest price target for EFX is $266.00, while the lowest price target for EFX is $179.00. The average price target represents a forecasted upside of 25.12% from the current price of $171.96.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EFX Analyst Ratings Over Time

Type	Current Forecast 9/8/25 to 9/8/26	1 Month Ago 8/9/25 to 8/9/26	3 Months Ago 6/10/25 to 6/10/26	1 Year Ago 9/8/24 to 9/8/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	15 Buy rating(s)	14 Buy rating(s)	13 Buy rating(s)	12 Buy rating(s)
Hold	6 Hold rating(s)	5 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$215.16	$214.05	$225.56	$283.53
Forecasted Upside	25.12% Upside	17.31% Upside	35.67% Upside	12.28% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Equifax Stock vs. The Competition

Type	Equifax	Industrials Companies	Broader Market
Consensus Rating Score	2.71	2.30	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	21.35% Upside	93.92% Upside	14.04% Upside
News Sentiment Rating	Positive News See Recent EFX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
8/21/2026	Rothschild & Co Redburn 4 of 5 stars	Simon Clinch Not Rated	Upgrade	Neutral ➝ Buy	$214.00 ➝ $235.00	+22.27%
8/13/2026	Weiss Ratings 5 of 5 stars		Upgrade	Sell (D+) ➝ Hold (C-)
7/22/2026	Deutsche Bank Aktiengesellschaft 2 of 5 stars		Set Target	Buy	$217.00 ➝ $208.00	+22.62%
7/22/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Haas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$220.00 ➝ $212.00	+24.03%
7/22/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Toni Kaplan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$243.00 ➝ $225.00	+30.64%
7/22/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Meuler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$245.00 ➝ $232.00	+34.70%
7/22/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Patnaik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$215.00 ➝ $200.00	+16.12%
7/22/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashish Sabadra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$222.00 ➝ $194.00	+12.64%
7/22/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$238.00 ➝ $220.00	+18.25%
7/22/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Neutral	$185.00 ➝ $190.00	+2.12%
Get the Latest News and Ratings for EFX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Equifax and its competitors with MarketBeat's FREE daily newsletter.
7/22/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$230.00 ➝ $210.00	+12.87%
7/22/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$265.00 ➝ $245.00	+42.25%
7/21/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Tong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral	$173.00 ➝ $182.00	+5.67%
7/13/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Market Perform	$195.00 ➝ $179.00	+3.93%
7/8/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin McVeigh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$220.00	+31.12%
7/2/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Kennedy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$222.00 ➝ $210.00	+25.37%
5/19/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$250.00 ➝ $225.00	+40.19%
4/24/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$220.00 ➝ $200.00	+16.12%
3/2/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold
2/5/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shlomo Rosenbaum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$253.00 ➝ $235.00	+26.13%
1/12/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rayna Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$271.00 ➝ $266.00	+19.81%
2/18/2025	Gordon Haskett Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chuck Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
2/7/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
12/12/2024	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Wurtzel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:42 PM ET.

Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, September 4, 2026. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

Here are some ways that investors could benefit from investing in Equifax Inc.:

Equifax Inc. recently reported strong financial performance in its latest quarterly results, beating analyst expectations with an earnings per share of $2.25 compared to the consensus estimate of $2.20, while also achieving revenue of $1.70 billion that met market forecasts and demonstrated 10.6% year-over-year growth, indicating robust demand for its data and analytics services.
The company maintains a favorable valuation relative to its growth prospects, currently trading at a price-to-earnings ratio of 31.16, which is supported by a P/E/G ratio of 1.80, suggesting that the stock may be undervalued given its consistent earnings growth and strong return on equity of 21.61%.
Equifax Inc. offers a stable income stream for investors through its dividend policy, with a current yield of 1.18% and a sustainable payout ratio of 39.37%, allowing the company to retain a significant portion of its earnings for reinvestment while still providing regular cash returns to shareholders.
Wall Street analysts maintain a positive outlook on the stock, with a consensus rating of "Moderate Buy" and an average price target of $215.16, which represents a significant potential upside from the current trading price, reflecting confidence in the company's long-term strategic position in the credit reporting industry.
The stock is currently trading at $177.31, which is well below its 52-week high of $271.84 and near its 52-week low of $150.74, presenting a potential entry point for value-oriented investors who believe the recent market overreaction has created a discount to the company's intrinsic value.

Equifax
Bear Case

Investors should be bearish about investing in Equifax Inc. for these reasons:

Equifax Inc. faces significant regulatory and competitive headwinds in its mortgage business, as the Federal Housing Finance Agency has moved to allow VantageScore 4.0 in government-backed mortgage workflows, which could erode the company's traditional dominance in credit scoring and pressure its revenue streams in this key segment.
There is notable insider selling activity, with CEO Mark Begor and other executives executing multiple sales of shares in recent months, including a recent sale of 37,791 shares by the CEO, which may signal a lack of confidence in the stock's near-term appreciation or a desire to diversify personal holdings.
The stock has experienced substantial volatility and a significant decline from its 52-week high, dropping from $271.84 to the current price of $177.31, reflecting a bearish trend that has resulted in a loss of over 34% in value over the past year, which may deter risk-averse investors.
Equifax Inc. carries a relatively high beta of 1.31, indicating that the stock is more volatile than the overall market, which means investors should expect larger price swings and higher risk exposure compared to less volatile sectors or companies with lower beta coefficients.
Recent institutional investor activity has been mixed, with some large funds reducing their positions in the stock, such as Van ECK Associates Corp trimming its holdings by 97.8% in the second quarter, which could indicate a shift in institutional sentiment or a rebalancing of portfolios away from the company.

EFX Forecast - Frequently Asked Questions

According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $215.16, with a high forecast of $266.00 and a low forecast of $179.00.

21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last twelve months. There are currently 6 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" EFX shares.

According to analysts, Equifax's stock has a predicted upside of 25.12% based on their 12-month stock forecasts.

Over the previous 90 days, Equifax's stock had 3 upgrades and 2 downgrades by analysts.

Equifax has been rated by research analysts at Barclays, BMO Capital Markets, BNP Paribas Exane, Citigroup, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Needham & Company LLC, Robert W. Baird, Rothschild & Co Redburn, Royal Bank Of Canada, The Goldman Sachs Group, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Equifax more than other "industrials" companies. The consensus rating for Equifax is Moderate Buy while the average consensus rating for "industrials" companies is Hold. Learn more on how EFX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Equifax Recommendations

MarketBeat monitors more than a dozen sources for Equifax analyst ratings, with the most recent rating issued on 8/21/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Equifax (EFX) Stock Forecast & Price Target